JP2023542279A5 - - Google Patents
Info
- Publication number
- JP2023542279A5 JP2023542279A5 JP2023512665A JP2023512665A JP2023542279A5 JP 2023542279 A5 JP2023542279 A5 JP 2023542279A5 JP 2023512665 A JP2023512665 A JP 2023512665A JP 2023512665 A JP2023512665 A JP 2023512665A JP 2023542279 A5 JP2023542279 A5 JP 2023542279A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence
- promoter
- composition according
- seq
- polynucleotide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010705069.XA CN113952472A (zh) | 2020-07-21 | 2020-07-21 | 用于治疗眼部疾病的组合物和方法 |
| PCT/IB2021/000509 WO2022018518A1 (en) | 2020-07-21 | 2021-07-20 | Compositions and methods for the treatment of eye diseases |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023542279A JP2023542279A (ja) | 2023-10-06 |
| JP2023542279A5 true JP2023542279A5 (cg-RX-API-DMAC7.html) | 2024-07-26 |
Family
ID=79459955
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023512665A Pending JP2023542279A (ja) | 2020-07-21 | 2021-07-20 | 眼疾患の処置のための組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230321281A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4185319A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023542279A (cg-RX-API-DMAC7.html) |
| CN (2) | CN113952472A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021312379A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3186826A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022018518A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3191540A1 (en) * | 2020-09-02 | 2022-03-10 | 4D Molecular Therapeutics Inc. | Codon optimized rpgrorf 15 genes and uses thereof |
| WO2026032020A1 (zh) * | 2024-08-06 | 2026-02-12 | 北京中因科技有限公司 | Aav介导的rpgr x连锁视网膜变性的基因编辑治疗方法 |
| WO2026119796A1 (en) * | 2024-12-05 | 2026-06-11 | Beacon Therapeutics Limited | Gene therapy vector |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006516027A (ja) * | 2002-12-02 | 2006-06-15 | ジェンベク、インコーポレイティッド | 眼関連障害の治療用材料および治療方法 |
| CN105120901A (zh) * | 2012-07-11 | 2015-12-02 | 宾夕法尼亚大学托管会 | Rpgr x染色体连锁视网膜退化的aav介导的基因治疗 |
| JP5971661B2 (ja) * | 2012-09-19 | 2016-08-17 | 国立大学法人 東京大学 | 神経活動依存的プロモータ活性を有するdna、及びこれを含むベクター |
| CN105980569A (zh) * | 2013-08-05 | 2016-09-28 | 莱顿大学医学中心附属莱顿教学医院 | 重组aav-crumbs同源物组合物及治疗lca-8和进行性rp的方法 |
| KR102281881B1 (ko) * | 2013-12-06 | 2021-07-27 | 엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔 (인쎄름) | 대상체의 망막 색소 상피에서 목적 폴리뉴클레오티드를 발현시키기 위한 방법 및 약학적 조성물 |
| EP3132051B1 (en) * | 2014-04-15 | 2019-03-20 | Applied Genetic Technologies Corporation | Codon optimized nucleic acid encoding a retinitis pigmentosa gtpase regulator (rpgr) |
| LT3137497T (lt) * | 2014-05-02 | 2021-07-26 | Genzyme Corporation | Aav vektoriai, skirti tinklainės ir cns genų terapijai |
| US20160346359A1 (en) * | 2015-05-01 | 2016-12-01 | Spark Therapeutics, Inc. | Adeno-associated Virus-Mediated CRISPR-Cas9 Treatment of Ocular Disease |
| GB201516066D0 (en) * | 2015-09-10 | 2015-10-28 | Young & Co Llp D | Treatment of retinitis pigmentosa |
| CN109640949B (zh) * | 2016-07-29 | 2022-11-25 | 加利福尼亚大学董事会 | 具有变异衣壳的腺相关病毒病毒体和其使用方法 |
| KR20250023600A (ko) * | 2017-06-30 | 2025-02-18 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 변이체 캡시드를 보유한 아데노-부속 바이러스 비리온 및 이의 사용 방법 |
| AU2019216257B2 (en) * | 2018-01-31 | 2025-11-20 | Research Institute At Nationwide Children's Hospital | Gene therapy for limb-girdle muscular dystrophy type 2C |
| TW202028225A (zh) * | 2018-09-21 | 2020-08-01 | 英商夜星克有限公司 | 用於治療色素性視網膜炎之組合物及方法 |
| CN115279421A (zh) * | 2020-01-10 | 2022-11-01 | 坚固生物科技公司 | 用于联合疗法的病毒载体 |
-
2020
- 2020-07-21 CN CN202010705069.XA patent/CN113952472A/zh active Pending
-
2021
- 2021-07-20 AU AU2021312379A patent/AU2021312379A1/en not_active Abandoned
- 2021-07-20 EP EP21845856.0A patent/EP4185319A4/en active Pending
- 2021-07-20 CA CA3186826A patent/CA3186826A1/en active Pending
- 2021-07-20 WO PCT/IB2021/000509 patent/WO2022018518A1/en not_active Ceased
- 2021-07-20 JP JP2023512665A patent/JP2023542279A/ja active Pending
- 2021-07-20 CN CN202180064480.6A patent/CN116615552A/zh active Pending
-
2023
- 2023-01-20 US US18/157,589 patent/US20230321281A1/en active Pending